Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

No Comments

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

No Comments

Generic levobunolol approved in Canada

Aug. 13, 1997

No Comments

FDA releases Staar's implantable contact lens for phase II trials

Aug. 11, 1997

No Comments

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

July 18, 1997

No Comments

New insights into glaucoma and implications for drug therapy

July 15, 1997

No Comments

Prostaglandins in early development at Allergan for glaucoma

July 4, 1997

No Comments

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

June 27, 1997

No Comments

Genistein prevents ischemic retinal degeneration in rats

June 25, 1997

No Comments

Merck & Co. discloses muscarinic antagonists for myopia

June 20, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

FDA approves expansion of Sunrise Technologies' hyperopia study

InSite Vision initiates phase II study of ISV-120

Generic levobunolol approved in Canada

FDA releases Staar's implantable contact lens for phase II trials

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

New insights into glaucoma and implications for drug therapy

Prostaglandins in early development at Allergan for glaucoma

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

Genistein prevents ischemic retinal degeneration in rats

Merck & Co. discloses muscarinic antagonists for myopia

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

Ocular RSS

Ocular
RSS